In young patients with type 1 diabetes, increased microangiopathic complications in adolescence were shown to be associated with significantly increased angiogenin levels, whereas maintaining tight glycemic control led to decreased levels [47]. This evidence concerns the gene ANG and type 1 diabetes mellitus.